Baltimore Secures $266M Verdict Against Opioid Distributors
A civil jury has found drug distributors McKesson and AmerisourceBergen liable for their role in Baltimore's opioid crisis, ordering them to pay over $266 million in damages. This verdict is part of a larger legal battle that has already secured over $400 million in settlements from other pharmaceutical companies. Baltimore's lawsuit argued that these distributors failed to monitor suspicious opioid orders, contributing to the city's high overdose rates. The city plans to use the funds for addiction-related programs and may seek additional billions in a forthcoming trial phase.